Skip to main
ARE
ARE logo

ARE Stock Forecast & Price Target

ARE Analyst Ratings

Based on 10 analyst ratings
Hold
Strong Buy 0%
Buy 40%
Hold 60%
Sell 0%
Strong Sell 0%

Bulls say

Alexandria Real Estate Equities Inc. is well-positioned for growth supported by its significant presence in key life science markets, which is bolstered by a record $10.8 billion backlog and increasing public sector demand. The company's focus on purpose-built space for life science, agtech, and technology tenants aligns with emerging trends in biotechnology and technology sectors, enhancing its long-term profitability prospects. Additionally, lower interest rates and potential recovery in biotech valuations may accelerate demand for lab space, further underpinning a favorable outlook for the company's operations.

Bears say

Alexandria Real Estate Equities Inc faces a negative outlook primarily due to several detrimental factors affecting its financial performance, including a year-over-year decline tied to lower operational results and management fees. There are significant concerns regarding expected occupancy erosion and an oversupply of life science properties, compounded by stagnating demand and funding constraints in the life science sector, leading to adverse effects on development leasing and earnings growth. Additionally, external pressures such as government shutdowns and changes in research grant reimbursements further exacerbate the company’s challenging operational landscape, prompting revisions in revenue estimates for the near future.

ARE has been analyzed by 10 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 40% recommend Buy, 60% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alexandria Real Estate Equities and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alexandria Real Estate Equities (ARE) Forecast

Analysts have given ARE a Hold based on their latest research and market trends.

According to 10 analysts, ARE has a Hold consensus rating as of Nov 7, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $94.70, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $94.70, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alexandria Real Estate Equities (ARE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.